Abstract
Autoantibodies against cytoplasmic components of neutrophil granulocytes (ACPA) were detected in 18 of 32 patients with Wegener's granulomatosis (WG), but in none of the controls (n = 900), including patients with glomerulonephritis, sarcoidosis, tuberculosis, polyarteritis nodosa, and connective tissue diseases, and healthy blood donors. The presence and, to a lesser extent, the titre of ACPA correlated with the severity and activity of the disease. ACPA could be detected in only three of 11 patients with the limited form of the disease and in none in complete remission. In contrast, in all patients with active extensive disease, ACPA were present in a higher titre, and in most of the patients in partial remission (eight of 12) antibodies were demonstrable, especially in those with frequent relapses. Furthermore, the antibody titre correlated significantly with the C-reactive protein concentration (P less than 0.05), but with none of the other laboratory parameters. In conclusion, ACPA have proven to be a highly specific disease marker of great clinical significance that provides us with a useful tool to confirm, or even establish. the diagnosis of WG.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Andrassy K., Darai G., Koderisch J., Ritz E. SSA (Ro)-antibodies in Wegener's granulomatosis. Klin Wochenschr. 1983 Sep 1;61(17):873–875. doi: 10.1007/BF01537463. [DOI] [PubMed] [Google Scholar]
- Conn D. L., McDuffie F. C., Holley K. E., Schroeter A. L. Immunologic mechanisms in systemic vasculitis. Mayo Clin Proc. 1976 Aug;51(8):511–518. [PubMed] [Google Scholar]
- Fauci A. S., Haynes B. F., Katz P., Wolff S. M. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983 Jan;98(1):76–85. doi: 10.7326/0003-4819-98-1-76. [DOI] [PubMed] [Google Scholar]
- Fauci A. S., Haynes B., Katz P. The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med. 1978 Nov;89(5 Pt 1):660–676. doi: 10.7326/0003-4819-89-5-660. [DOI] [PubMed] [Google Scholar]
- Fauci A. S. Immunoregulation in autoimmunity. J Allergy Clin Immunol. 1980 Jul;66(1):5–17. doi: 10.1016/0091-6749(80)90132-3. [DOI] [PubMed] [Google Scholar]
- Gross W. L., Lüdemann G., Kiefer G., Lehmann H. Anticytoplasmic antibodies in Wegener's granulomatosis. Lancet. 1986 Apr 5;1(8484):806–806. doi: 10.1016/s0140-6736(86)91820-9. [DOI] [PubMed] [Google Scholar]
- Hind C. R., Pepys M. B. Anticytoplasmic antibodies in Wegener's granulomatosis. Lancet. 1985 Jun 8;1(8441):1336–1337. doi: 10.1016/s0140-6736(85)92832-6. [DOI] [PubMed] [Google Scholar]
- Hind C. R., Winearls C. G., Lockwood C. M., Rees A. J., Pepys M. B. Objective monitoring of activity in Wegener's granulomatosis by measurement of serum C-reactive protein concentration. Clin Nephrol. 1984 Jun;21(6):341–345. [PubMed] [Google Scholar]
- Nicholson G. A., McLeod J. G., Griffiths L. R. Acetylcholine receptor antibody in the diagnosis of myasthenia gravis. Med J Aust. 1983 Oct 1;2(7):334–337. doi: 10.5694/j.1326-5377.1983.tb122491.x. [DOI] [PubMed] [Google Scholar]
- van der Woude F. J., Rasmussen N., Lobatto S., Wiik A., Permin H., van Es L. A., van der Giessen M., van der Hem G. K., The T. H. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet. 1985 Feb 23;1(8426):425–429. doi: 10.1016/s0140-6736(85)91147-x. [DOI] [PubMed] [Google Scholar]